Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …

Glioblastoma multiforme is the most common, aggressive and lethal type of brain tumor. It is
a stage IV cancer disease with a poor prognosis, as the current therapeutic options (surgery …

Simple Summary Glioblastoma is a devastating malignancy that has continued to prove
resistant to a variety of therapeutics. No new systemic therapy has been approved for use …

Numerous non-oncologic medications have been found in the last decade to have anti-
cancer properties. While the focus in oncology research should clearly remain on deriving …

Simple Summary Introducing novel and effective treatments against glioblastoma (GBM)
remains an arduous journey as reflected in the negative outcome of most clinical trials. The …

Introduction: Glioblastoma, the most common malignant brain tumor, exhibits a poor
prognosis with little therapeutic progress in the last decade. Novel treatment strategies …

Abstract Background Glioblastoma Multiforme is the deadliest type of brain tumor and is
characterized by very poor prognosis with a limited overall survival. Current optimal …

Simple Summary Despite the continuous development of treatment technology,
glioblastoma remains a challenge for modern medicine. The standard of care remains a …

Introduction: Treatments for brain cancer have radically evolved in the past decade due to a
better understanding of the interplay between the immune system and tumors of the central …

Glioblastoma is a heterogeneous tumour type which is highly resistant to radiotherapy and
chemotherapy. Clinical results following standard therapy as well as new approaches using …